In Focus

As we age, the #immunesystem weakens making us more vulnerable to #infectiousdiseases. #WIW2023 #TheBigCatchUp Want to find out more? 👇

Have you heard of #myelofibrosis, a rare form of blood cancer? Dr. John Mascarenhas, a hematologist oncologist, explains what this condition is, how it presents and how it is diagnosed. Watch the video here: gsk.to/3KQpI7P

💊 Today is the day! Bring your unwanted, unused, and expired medicines to the 24th@DEAHQQ's National Prescription Drug#TakeBackDayy between 10AM - 2PM. 💊 Find a participating location near you atakebackday.dea.govjw #ppswgw#myoldmedsd#safedisposaladV

During the 2022 #TakeBackDay, the @DEAHQ collected over 324 tons of household medicines! Can we break that record on Sat 4/22? Find a participating location at: 💊takebackday.dea.govw #ppswgg#myoldmedss#safedisposallz

Real conversations generate impactful change. At this year’s @NMQF Summit on Health Disparities, VP of Commercial Communications, Sri Ramaswami, joined a panel discussion on Addressing Barriers to Patient Accessibility to Necessary Therapies. #NMQFLeadershipSummit

The next @DEAHQ's National Prescription Drug #TakeBackDay will be held on Saturday, April 22! Learn how to prepare, what will be collected, and how to safely store your medicine until the event at: 💊MyOldMeds.com/blogrV. #ppswgw#myoldmedsd#safestorageg#safedisposaladH

Congrats to the @startupfiu students in the GSK #Innovation Challenge addressing low vaccination rates in the Hispanic community. The winners found large companies with a big Hispanic workforce and created solutions including an employer caregiver toolkit and caretaker programs.

#News for #investors and #media: Today we announced the proposed acquisition of @BELLUSHealth, a clinical stage biopharmaceutical company that further strengthens our specialty medicines and respiratory pipeline. Find out more: gsk.to/41zwzb7

While everyone can be impacted by #myelofibrosis, certain risk factors can increase the likelihood that a person will develop it. Click here to learn more: gsk.to/3zRZBXY

Are you familiar with the signs and symptoms of #myelofibrosis? In early stages, ~1/3 of people with the disease may not have any, but as it progresses, patients may experience a variety of symptoms that differ from person-to-person. Learn more: gsk.to/3KRNW1B